Auph Stock

Auph Stock

Aurinia Pharmaceuticals Inc. Ranked amongst corporations with meaningful PB Ratio only. Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical firm, engages in the analysis, development, and commercialization of therapeutic drugs for the remedy of autoimmune ailments in Canada, the United States, China, and Switzerland. Ranked among financial administration principle and observe for ca intermediate ipc businesses with meaningful Fast Ratio only. Ranked among organizations with meaningful EV-to-EBIT only. Ranked among providers with meaningful Interest Coverage only.Auph Stock

GuruFocus has detected 5 Warning Indicators with Aurinia Pharmaceuticals Inc AUPH. Ranked amongst companies with meaningful ROA % only. Ranked amongst organizations with meaningful ROC (Joel Greenblatt) % only. Ranked among businesses with meaningful 3-Year Income Growth Price only. Aurinia Pharmaceuticals Inc is a biopharmaceutical organization. Ranked among companies with meaningful EV-to-Revenue only. Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company.

This generated report has historical data on financials with interactive charts, technical indicators, and 5-year peer comparison trend charts. Ranked amongst organizations with meaningful Operating Margin % only. Value stocks can continue to be undervalued by the marketplace for extended periods of time. Ranked among leopards staff is prepared to go to work garrett says corporations with meaningful PS Ratio only. Ranked among companies with meaningful Net Margin % only. Ranked amongst organizations with meaningful Money-to-Debt only.

This generated report has historical data on financials with interactive charts, technical indicators, and five-year peer comparison trend charts. Ranked among corporations with meaningful Operating Margin % only. Worth stocks can continue to be undervalued by the market place for extended periods of time. Ranked amongst firms with meaningful PS Ratio only. Ranked among providers with meaningful Net Margin % only. Ranked amongst organizations with meaningful Cash-to-Debt only.

Ranked among companies with meaningful Existing Ratio only.

Aurinia Pharmaceuticals Inc. GuruFocus has detected 5 Warning Indicators with Aurinia Pharmaceuticals Inc AUPH. Ranked among providers with meaningful ROA % only. Ranked among firms with meaningful ROC (Joel Greenblatt) % only. Ranked amongst businesses with meaningful three-Year Revenue Growth Rate only. Aurinia Pharmaceuticals Inc is a biopharmaceutical corporation. Ranked amongst firms with meaningful EV-to-Revenue only. Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company.

GuruFocus has detected 5 Warning Signs with Aurinia Pharmaceuticals Inc AUPH. Ranked amongst firms with meaningful ROA % only. Ranked among companies with meaningful ROC (Joel Greenblatt) % only. Ranked amongst firms with meaningful three-Year Income Development Price only. Aurinia Pharmaceuticals Inc is a biopharmaceutical corporation. Ranked amongst companies with meaningful EV-to-Revenue only. Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical organization.

GuruFocus has detected 5 Warning Indicators with Aurinia Pharmaceuticals Inc AUPH. Ranked among companies with meaningful ROA % only. Ranked amongst providers with meaningful ROC (Joel Greenblatt) % only. Ranked amongst corporations with meaningful 3-Year Revenue Development Price only. Aurinia Pharmaceuticals Inc is a biopharmaceutical corporation. Ranked amongst firms with meaningful EV-to-Income only. Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical firm.

Ranked amongst companies with meaningful three-Year EPS without the need of NRI Development Rate only. Ranked amongst businesses with meaningful EV-to-EBITDA only. Ranked amongst companies with meaningful Current Ratio only. Ranked amongst providers with meaningful ROE % only. Ranked amongst businesses with meaningful 3-Year EBITDA Development Rate only. (AUPH), a clinical stage biopharmaceutical company focused on the international immunology industry, currently announced the initiation of its Phase two trial evaluating voclosporin ophthalmic solution for the remedy of dry eye syndrome.

Ranked among businesses with meaningful ROE % only. Ranked amongst providers with meaningful Interest Coverage only. Ranked among corporations with meaningful Speedy Ratio only.

Leave a Reply